International audienceOne of the main challenges in multiple sclerosis (MS) is to predict disease progression based on patient characteristics and therapeutic strategies. We therefore performed a systematic review to critically appraise the composite tools available for this purpose
Over the last decade, more than ten new disease modifying treatments (DMTs) for multiple sclerosis (...
Background: Effective therapeutic strategies to preserve function and delay progression in multiple ...
Consensus; Early detection; Secondary progressive multiple sclerosisConsenso; Detección precoz; Escl...
International audienceBackground:One of the main challenges in multiple sclerosis (MS) is to predict...
Multiple sclerosis is an incurable chronic inflammatory disease that typically first manifests in ea...
The natural history of relapsing remitting multiple sclerosis (RRMS) is variable and prediction of i...
Multiple sclerosis is an idiopathic inflammatory disease of the central nervous system and the secon...
Background: Multiple sclerosis (MS) is a chronic neuroinflammatory disease affecting about 2.8 mill...
Background Multiple sclerosis (MS) is a neurological condition whose symptoms, severity, and progres...
<div><p>Background</p><p>New agents with neuroprotective or neuroregenerative potential might be exp...
The course of multiple sclerosis begins with a relapsing-remitting phase, which evolves into a secon...
Multiple sclerosis (MS) is the commonest non-traumatic disabling disease to affect young adults. The...
Multiple sclerosis (MS) is an immune system demyelinating and neurodegenerative disease of the centr...
Over the last decade, more than ten new disease modifying treatments (DMTs) for multiple sclerosis (...
Background: Effective therapeutic strategies to preserve function and delay progression in multiple ...
Consensus; Early detection; Secondary progressive multiple sclerosisConsenso; Detección precoz; Escl...
International audienceBackground:One of the main challenges in multiple sclerosis (MS) is to predict...
Multiple sclerosis is an incurable chronic inflammatory disease that typically first manifests in ea...
The natural history of relapsing remitting multiple sclerosis (RRMS) is variable and prediction of i...
Multiple sclerosis is an idiopathic inflammatory disease of the central nervous system and the secon...
Background: Multiple sclerosis (MS) is a chronic neuroinflammatory disease affecting about 2.8 mill...
Background Multiple sclerosis (MS) is a neurological condition whose symptoms, severity, and progres...
<div><p>Background</p><p>New agents with neuroprotective or neuroregenerative potential might be exp...
The course of multiple sclerosis begins with a relapsing-remitting phase, which evolves into a secon...
Multiple sclerosis (MS) is the commonest non-traumatic disabling disease to affect young adults. The...
Multiple sclerosis (MS) is an immune system demyelinating and neurodegenerative disease of the centr...
Over the last decade, more than ten new disease modifying treatments (DMTs) for multiple sclerosis (...
Background: Effective therapeutic strategies to preserve function and delay progression in multiple ...
Consensus; Early detection; Secondary progressive multiple sclerosisConsenso; Detección precoz; Escl...
DOI
Add to ORKG